Julia Thornton Snider, PhD
Articles
The Potential Impact of CAR T-Cell Treatment Delays on Society
Treatment delays limit the social value generated by chimeric antigen receptor (CAR) T-cell therapy for the treatment of pediatric acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
The Well-Being of Long-Term Cancer Survivors
This study compares the well-being of long-term cancer survivors with that of US residents of similar age and demographic characteristics, patients recently diagnosed with cancer, and individuals with chronic illness.
The Option Value of Innovative Treatments for Non–Small Cell Lung Cancer and Renal Cell Carcinoma
Option value is the benefit a therapy provides patients by enabling them to survive to the next innovation.
The Social Value of Childhood Vaccination in the United States
Vaccination of children born in the United States in 2009 will save 1.2 million quality-adjusted life-years, generating $184 billion in social value net of vaccination costs.
Impact of Type 2 Diabetes Medication Cost Sharing on Patient Outcomes and Health Plan Costs
An analysis of claims from over 90,000 patients with type 2 diabetes (T2D) demonstrates that increased medication cost sharing is associated with higher rates of hospitalization and increased plan costs.
Impact of Oral Nutritional Supplementation on Hospital Outcomes
Instrumental variables regression analysis indicated that inpatient oral nutritional supplement use decreased length of stay, episode cost, and 30-day readmission probability.
